# ImmVira Presents Clinical Data from Three Bladder Cancer Studies at ESMO 2026

- Source: PR Newswire
- Published: 2026-10-23T00:00:00+00:00
- Category: Local
- Original: https://www.prnewswire.com/news-releases/immvira-presents-clinical-data-from-three-bladder-cancer-studies-at-esmo-2026-302915052.html
- Canonical: https://groundlevelnews.com/story/immvira-presents-clinical-data-from-three-bladder-cancer-studies-at-es-622f6f/

SUZHOU, China, Oct. 22, 2026 /PRNewswire/ -- ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic immunotherapy candidate, MVR-T3011, will be presented at the 2026 European Society for Medical Oncology (ESMO) Congress....

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._